I agree that this site is using cookies. You can find further informations here.
X
Arca, M
~ 900  results:
Search for persons X
?
1

Lomitapide hepatic safety: A long-term retrospective analys..:

Cegla, J. ; Larrey, D. ; D'Erasmo, L...
Atherosclerosis Plus.  54 (2023)  - p. S2-S3 , 2023
Link: https://doi.org/10.1016/..
 
?
2

P2.16-06 A Phase 2 Study of Ifinatamab Deruxtecan (I-DXd; D..:

Rudin, C. ; Johnson, M. ; Girard, N....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S377 , 2023
Link: https://doi.org/10.1016/..
 
?
3

OC 10.4 Proprotein Convertase Subtilisin Kexin Type 9 Inhib..:

Cammisotto, V. ; Baratta, F. ; Nocella, C....
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 100582 , 2023
Link: https://doi.org/10.1016/..
 
?
4

P490 MANAGEMENT OF SEVERE HYPERCHOLESTEROLEMIA IN ITALY: EV..:

Arca, M ; Solini, A ; Calabrò, P..
European Heart Journal Supplements.  25 (2023)  Supplement_D - p. D235-D235 , 2023
Link: https://doi.org/10.1093/..
 
?
5

Effects of patient characteristics on volanesorsen efficacy..:

Witztum, J.L. ; Gaudet, D. ; Freedman, S....
Atherosclerosis.  355 (2022)  - p. 215 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Lomitapide in the long-term real-world management of HoFH –..:

Cegla, J. ; d'Erasmo, L. ; Steward, K....
Atherosclerosis Plus.  49 (2022)  - p. S2-S3 , 2022
Link: https://doi.org/10.1016/..
 
?
7

ANGPTL3 and PCSK9 interact and show coordinated metabolic r..:

Bini, S. ; Pecce, V. ; D'Erasmo, L....
Atherosclerosis.  355 (2022)  - p. 86 , 2022
Link: https://doi.org/10.1016/..
 
?
8

The genetic lack of ANGTPL3 does not alter HDL functionalit:

Minicocci, I. ; Ossoli, A. ; Turri, M....
Atherosclerosis.  355 (2022)  - p. 16-17 , 2022
Link: https://doi.org/10.1016/..
 
?
9

LDL-cholesterol levels and LDL polygenic score in a cohort ..:

Casula, M. ; Olmastroni, E. ; Gazzotti, M....
Atherosclerosis.  355 (2022)  - p. 17 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Lomitapide in the long-term real-world management of HoFH –..:

D'Erasmo, L. ; Steward, K. ; Di Costanzo, A....
Atherosclerosis.  355 (2022)  - p. 28 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Role of NAFLD-associated genetic variants on renal function..:

Di Costanzo, A. ; Baratta, F. ; D'Erasmo, L....
Atherosclerosis.  355 (2022)  - p. 198-199 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Lomitapide effectively reduces triglyceride (TG) levels in ..:

Cefalù, A.B. ; D'Erasmo, L. ; Giammanco, A....
Atherosclerosis.  355 (2022)  - p. 45 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Real-world use of PCSK9 inhibitors in familial hypercholest..:

D'Erasmo, L. ; Arca, M. ; Celant, S....
Atherosclerosis.  355 (2022)  - p. 11 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Application of ACMG guidelines for classification of varian..:

Minicocci, I. ; Di Costanzo, A. ; D'Erasmo, L....
Atherosclerosis.  331 (2021)  - p. e217 , 2021
Link: https://doi.org/10.1016/..
 
?
15

High TG to HDL ratio plays a significant role on atheroscle..:

Scicali ; D'Erasmo, L. ; Cluzel, P....
Atherosclerosis.  331 (2021)  - p. e237 , 2021
Link: https://doi.org/10.1016/..
 
1-15